68

La tech au service de la santé féminine lève 60 millions

December 8, 2021

Share this story:

More from our blog

Breaking Barriers at Aspivix™

Read More about Breaking Barriers at Aspivix™

Aspivix Featured in a $360B Women’s Health Ghost Market Report

Read More about Aspivix Featured in a $360B Women’s Health Ghost Market Report

Aspivix on TV in La Télé VAUD FRIBOURG!

Read More about Aspivix on TV in La Télé VAUD FRIBOURG!

The Medical Instrument Behind 135 Years of Women’s Pain

Read More about The Medical Instrument Behind 135 Years of Women’s Pain

Exploring Femtech

Read More about Exploring Femtech

New Cervical Device Designed for Gentle Gynecology

Read More about New Cervical Device Designed for Gentle Gynecology

Aspivix Selected as Finalist for the 2024 Digital Health Hub Foundation: Digital Health Awards

Read More about Aspivix Selected as Finalist for the 2024 Digital Health Hub Foundation: Digital Health Awards

Aspivix and Tia Partner to Enhance IUD procedures with Carevix™ across the USA

Read More about Aspivix and Tia Partner to Enhance IUD procedures with Carevix™ across the USA

CDC issues new guidelines on pain management for IUD procedures

Read More about CDC issues new guidelines on pain management for IUD procedures

Aspivix Announces MHRA Approval for the Groundbreaking Cervical Stabilizer Carevix™ for a painless contraceptive care in the United Kingdom

Read More about Aspivix Announces MHRA Approval for the Groundbreaking Cervical Stabilizer Carevix™ for a painless contraceptive care in the United Kingdom